Organ Preservation With Durvalumab-based Immunotherapy in Combination With Chemoradiation as Definitive Therapy for Early Stage Esophageal Adenocarcinoma With Indication for Radical Surgery
Condition(s):Esophagus AdenocarcinomaLast Updated:November 27, 2023Recruiting